LJP

pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases; namely systemic lupus erythematosus; Rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; grave's disease; myasthenia gravis; hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and goodpasture's syndrome